Member Info for Scinv_temp

The patent situation does not stop anyone from selling ifnb or other ifns. Just because the company does not own the concept it does not mean the product is useless. The offer was for £250M (less than current mcap) + royalties.

What the patent surely does however is protect them from a malicious player that patents something similar and then makes a claim against them based on similarity.

No Matterhorn, rhe question is whether others are allowed to come up with their own ifnb formulations for covid or flu or whatever. And the answer to me is very clear that they can.

Here is another patent that tries to alleviate that issue by basically patenting the a polymer to conjugate ifnb prior to inhalation, including for flu. If that worked (and they actually discovered that polymer/conjugation method) then they would have had a stronger case, it is from the 90's

https://patents.google.com/patent/JP2002527491A5/en?oq=JP2002527491A5

On synairgen flu patent, jere is one that was ceased because someone else claimed priority, if there is another one that still stands then if check for difderences perhaps you can find out where they base it. I personally don't care to do all that work. I do think however the covid patents are based in part on combination with corticosteroids. I doubt that has much chance either.

https://patents.google.com/patent/GB201008114D0/en?assignee=Synairgen&oq=Synairgen

It can only be that. Or do you think sng discovered that ifnb may be useful against flu virus? AGAIN do you understand patents at all?

*are not about calling dibs either

Retired40, I'm sure he does

Matterhorn, others have used it before they did. It doesn't matter what they say. Patents are about calling dibs either (if there is something not exactly patented before there), many of them fall because they are obvious.

When commercialising it yes. And how will that go you think? My guess is they are not even going to try.

Here's another potential devil that is going to be hard to find details about. Does sng have any patents on how to manufacture the specific formulation, or do these belong exclusively to the german company that they work with (there had to be a technology transfer iirc for akron to be another source, who owns that technology?). A joint patent perhaps? I have no idea. If you do it would be helpful to post it here.

To be clear, the patent covers sng001 specifically.

Then why are you posting the patent text as if that matters. Do you think sng discovered ifnb, or the potential use against any virus? Or the potential benefit of nebulising it?
Sng discovered none of those things.

FDA has nothing to do with patents.

Matterhotn. Patents ARE NOT LAW, understand this. You can patent but the moment of truth is when someone else does something similar. It is then that the company has to decide whether to challenge them or not. It is not the obligation of any other company to ask, it is the holder that needs to raise the issue and if they are succesful then they can stop the competitor and/or receive compensation or settle etc

Here is an example for covid, inhaled ba1 in China since the very beginning of the pandemic, published Feb 2020, long before sng covid patents

https://journals.lww.com/imd/fulltext/2020/06000/translation__management_of_coronavirus_disease.4.aspx

Here is the first attempt used inhaled interferon as prophylactic against a cold virus. This study was 1962.
https://cris.maastrichtuniversity.nl/files/538354/guid-b70a2bce-f956-4f3b-997f-72fe904f3da2-ASSET1.0.pdf

Here is another patent about sars and other viruses (just as weak as a blanket patent ifn b as is sng's)
2008
https://patents.google.com/patent/US8551469B2/en 

Here is another from 1999 about nebulised ifnba1 in the context of lung cancer
pubmed.ncbi.nlm.nih.gov/8008985/

I have posted these and others several times before, I even skipped all the alphas this time. Most of these posts have been reported into oblivion as this one probably be as well.

But if that is not enough, you have reports from France testing it, China they've been doimg it forever anyway, now a full kit in development in Argentina. There are others, if it continues to show promise, many will pop with their own versions as I predicted before they even started the phase 3 and you thought it was impossible. There is a point when it really is not worth the same thing again and again. Not going to discuss this any further, you want to believe that sng are the only potential shop with inhaled ifnb for this or ANY virus, go ahead and continue to beleive that but keep this in mind, the point of the patent is that you make a secret unformation useful to the public and in return you get some protection for some time. If the information is alredy out there, anyone can do it.

Doc it's very simple,

Inhaled forms of ifns includong ifnb have been developed several times in the past 60 years, numerous studies published on it some of which I have posted here before. To me it is perfectly clear that sng does not own that concept which long pre existed the company. Even for covid, it was tested and published before by others and the same thing happened with original sars and mers and pretty much respiratory virus out there. This is a fact.

Therefore sng (as well as everyone else) can only own their own product, not the concept of it.

Woodstock I think it was a rather benign reply to this.

"Schrow123

Wed 19:41

Posts: 685

Price: 142.20

Seriously, this guy seems to live in a self-imposed mental prison of imaginary persecution, unwarranted pessimism, massive cynicism and complete paranoia.

I honestly think he just needs a hug.

But in the meantime, if you could kindly bore off...or at least keep your posts constructive and reigned in.

Recommend (12)"

It is RM who should answer that question, and saying "we are aware" does not count as a valid answer.
From my pov, I already said my opinion several times, no need to repeat.

Actually the interesting part is ProinVet specialises in veterinary products. Can you imagine Schrow123's face if sng's wind is stollen by a pet shop ? :)

https://www.linkedin.com/mwlite/company/proinvet-innovations

I started selling when as I saw the activ 2 supply issue (which wasn't immediately, ironically I think it was woodstock who pointed it out :) ), because that increased the risk there as well. This type of thing is each to their own. Someone said before that I was so ****ed off because I was too exposed on sng, it turns out they were right :) (I honestly do not remember who it was). It was 30% of a decent size portfolio at some point, then it became more actually, but mostly because I was getting rid of stuff and not buying back as things played out (for example I got rid of all antibody cos before I started selling sng).

Anyway, the antibodies story is an old story yes, but I never said I'm a virologist (in fact I have specifically denied it in the past), I found out when I started digging after the Bastard et al paper in October. SNG knew this was a possibility from before that and they should have acted quickly, surely you don't think the activ people don't know what they are doing.

Perhaps not every hospital has the tests readily available, but for the hospital setting (because it is a known condition) they do exist, no development was needed and scaling up of tests for hospitalised patients as soon as they are admited (they do a multitude of blood tests to them anyway) wouldn't be an issue given the urgency. Most of the time spent with the covid tests was to find out which ones actually work well, not an issue in this case. What would have been a task but not an impossible one, would be to develop one for self use at home or the pharmacy. Perhaps they bet too much on someone taking them over early and then doing it their way.

Also a comment on the pause. In the active document it is clear, the trial was paused and after thr interim anlysis (so after they presented the results in September) it was decided close it. Two different things, not 2 words for the same meaning.